Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Africa FDI reaches $70 billion in 2025

    July 8, 2026

    Brent crude rises to $74.16 as oil prices climb

    July 8, 2026

    DRC Ebola trial tests therapies as outbreak spreads

    July 8, 2026
    Facebook X (Twitter) Instagram
    Djibouti LiveDjibouti Live
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Djibouti LiveDjibouti Live
    Home » Unraveling aspartame controversy and its potential cancer link
    Health

    Unraveling aspartame controversy and its potential cancer link

    July 1, 2023
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email

    Artificial sweeteners have found a prominent place in our kitchens, becoming a staple for those seeking to reduce or eliminate sugar due to diabetes and other health factors. However, recent reports about aspartame, a commonly used sweetener, have set off alarm bells. The International Agency for Research on Cancer (IARC) is predicted to designate aspartame as “potentially cancer-inducing to humans” in July 2023.

    Unraveling aspartame controversy and its potential cancer link

    But before fear takes hold, it’s important to understand what aspartame is, its common uses, and the potential impact of the IARC’s imminent ruling. Discovered in 1965 and approved by the US FDA as a food additive in 1975, aspartame has become a go-to sweetening agent due to its intense sweetness -nearly 200 times that of ordinary table sugar – and the fact that it contributes no calories to our diet. Unlike other artificial sweeteners, it also leaves no bitter aftertaste.

    These features have made aspartame a favorite among health-conscious consumers and a mainstay in the food and beverage industry. However, there’s another side to this sugar substitute. A French observational study conducted in 2022 on 100,000 adults indicated a slight increase in cancer risk for those who consumed large amounts of artificial sweeteners, including aspartame.

    The use of aspartame is widespread, featuring in an array of low-calorie products from fizzy drinks like Diet Coke, sugar-free confectionery, desserts, and low-fat yogurts to ice creams and even cough syrups. It also serves as a flavor enhancer in baked and canned goods, candies, puddings, and powdered mixes of coffee, tea, and juice.

    The IARC’s forthcoming ruling, formulated on the basis of reviewing 1,300 published studies on aspartame and its potential risks, holds significant implications. The report includes recommendations from the WHO’s expert committee on food additives (JECFA) as well as national regulators.

    The designation of aspartame as ‘possibly carcinogenic’ doesn’t definitively indicate it causes cancer but suggests a possible association with the disease, based on either sufficient evidence of cancer-causing potential in animals or strong indications of carcinogenic-like characteristics, albeit without definitive evidence of causing cancer in humans.

    The potential classification of aspartame as a possible carcinogen aims to stimulate more research on food and consumer safety, say sources close to IARC. In response to these concerns, while some food and beverage companies continue to advocate their use of aspartame, others have adjusted their recipes to incorporate alternatives. A few companies in the US have even eliminated aspartame from their products entirely.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    DRC Ebola trial tests therapies as outbreak spreads

    July 8, 2026

    Congo Ebola cases rise as outbreak widens

    June 19, 2026

    Ebola cases in DR Congo rise as WHO warns on spread

    June 13, 2026

    DR Congo Ebola cases rise to 598 as deaths reach 115

    June 10, 2026

    WHO reports 507 Ebola cases across Congo and Uganda

    June 8, 2026

    Global health bodies seek $518 million for Ebola response

    June 6, 2026
    Latest News

    Africa FDI reaches $70 billion in 2025

    July 8, 2026

    Brent crude rises to $74.16 as oil prices climb

    July 8, 2026

    DRC Ebola trial tests therapies as outbreak spreads

    July 8, 2026

    Developing Asia FDI reaches $644 billion in 2025

    July 8, 2026

    Portugal fall to Spain as Ronaldo legacy closes

    July 7, 2026

    Italy and GCC sign MoU to expand political cooperation

    July 7, 2026

    Macron visit puts Syria reconstruction deals in focus

    July 7, 2026

    Iraq sets Halliburton contract for Basra oil fields

    July 6, 2026
    © 2026 Djibouti Live | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.